HoldsUp

Robin Carhart-Harris

Robin Carhart-Harris is a neuroscientist specializing in psychedelic research and psychedelic psychiatry. His research investigates the neurobiological mechanisms and clinical applications of substances such as psilocybin, LSD, MDMA, DMT, and ketamine. His published work focuses on their therapeutic potential for conditions like major depressive disorder, as well as their effects on brain connectivity, neuroplasticity, and subjective experience.

25 claims checked on air: 1 contradicted 2 overstated 18 supported 4 unverified

What they said on air - unverified

2 citing their own research

0:55:15unverifiedvery lowWhy Your Brain is Stuck: The Truth About Psychedelics and Pl

Psychologist Betty Eisner introduced the concept of the psychosocial matrix in the 1960s as a third factor alongside set and setting in psychedelic therapy.

"Back in the '60s, I believe it was a psychologist, Betty Eisner, brought in a third component, which she called matrix, the psychosocial matrix." (said at 0:55:15)

No published record matching the claim that psychologist Betty Eisner introduced the concept of the 'psychosocial matrix' (or matrix) as a third factor alongside set and setting in the 1960s was located; this does not prove the claim false.

1:03:11unverifiedvery lowWhy Your Brain is Stuck: The Truth About Psychedelics and Pl

Evidence for psychedelic-induced neuroplasticity is primarily based on rodent studies, with human evidence not yet clearly established.

"Well, in mice. But human evidence of neuroplasticity, it ain't really there yet. You know, we're working on it. We'll have some brain imaging markers of it quite soon. Um, but the whole story is based on work in little mice brains and not much else, to be honest." (said at 1:03:11)

No published record matching the claim that evidence for psychedelic-induced neuroplasticity is primarily based on rodent studies and not yet clearly established in humans was located; this does not prove the claim false.

1:06:07unverifiedvery lowWhy Your Brain is Stuck: The Truth About Psychedelics and Pl

Psilocybin has not worked well for Alzheimer's disease because patients cannot remember their experience or trip.

"Alzheimer's, you know, there's been a little bit of work. People can't remember their trip. They can't remember the experience, and so it hasn't worked that well so far." (said at 1:06:07)

No published record matching the claim that psilocybin has failed or proved ineffective in Alzheimer's disease because patients cannot remember their psychedelic experience was located; this does not prove the claim false. Published literature on psilocybin and other psychedelics in Alzheimer's disease remains largely exploratory, comprising preclinical studies, narrative reviews, and theoretical rationales focusing primarily on biological mechanisms (such as 5-HT2A agonism, neuroplasticity, BDNF signaling, and anti-inflammatory effects) and preliminary management of comorbid neuropsychiatric symptoms.

1:17:47unverifiedvery lowWhy Your Brain is Stuck: The Truth About Psychedelics and Pl

Jack Gallant's research team at UC Berkeley has used brain decoding algorithms on neuroimaging data to predict what movies individuals are watching or what audio scripts they are listening to.

"People like Jack Gallant at UC Berkeley have used that approach to predict, um, what people are viewing in terms of movie watching, um, what people are listening to in terms of audio scripts." (said at 1:17:47)

No published record matching Jack Gallant's research team at UC Berkeley using brain decoding algorithms on neuroimaging data to predict what movies individuals are watching or what audio scripts they are listening to was located; this does not prove the claim false.

Fact-checked episodes

Publications